These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19912878)

  • 1. TYR-MIF-1, but not MIF-1 or morphine, decreases cyclic AMP-dependent protein kinase activity extracted from HeLa cells.
    Zhang XY; Zadinat JE; Ehrlich M; Kastint AJ
    Mol Cell Neurosci; 1992 Aug; 3(4):348-53. PubMed ID: 19912878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
    Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
    Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
    Harrison LM; Zadina JE; Banks WA; Kastin AJ
    Brain Res Dev Brain Res; 1993 Oct; 75(2):207-12. PubMed ID: 7903224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of Tyr-MIF-1 at opiate receptor sites.
    Zadina JE; Kastin AJ
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1303-5. PubMed ID: 2880352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Gulden H; Bungart KJ
    Life Sci; 1989; 44(8):555-61. PubMed ID: 2564620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorphins, cytochrophins, and human beta-casomorphins bind to antiopiate (TYR-MIE-1) as well as opiate binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Brantl V
    Life Sci; 1990; 47(8):PL25-30. PubMed ID: 1976197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
    Banks WA; Kastin AJ; Ehrensing CA
    J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies of Tyr-MIF-1 with human lymphocytes.
    Chi DS; Strimas JH; Kastin AJ
    Brain Res Bull; 1989 Dec; 23(6):549-52. PubMed ID: 2575445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide transport system-1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for either.
    Maresh GA; Kastin AJ; Brown TT; Zadina JE; Banks WA
    Brain Res; 1999 Aug; 839(2):336-40. PubMed ID: 10519058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2).
    Hackler L; Kastin AJ; Zadina JE
    Peptides; 1994; 15(6):945-50. PubMed ID: 7991457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.